Analgesic use for knee and hip osteoarthritis in community-dwelling elders
- PMID: 21992521
- PMCID: PMC3221937
- DOI: 10.1111/j.1526-4637.2011.01249.x
Analgesic use for knee and hip osteoarthritis in community-dwelling elders
Abstract
Objective: To examine the prevalence and correlates of non-opioid and opioid analgesic use and descriptively evaluate potential undertreatment in a sample of community-dwelling elders with symptomatic knee and/or hip osteoarthritis (OA).
Design: Cross-sectional.
Setting: Health, Aging, and Body Composition Study.
Patients: Six hundred and fifty-two participants attending the year 6 visit (2002-03) with symptomatic knee and/or hip OA.
Outcome measures: Analgesic use was defined as taking ≥1 non-opioid and/or ≥1 opioid receptor agonist. Non-opioid and opioid doses were standardized across all agents by dividing the daily dose used by the minimum effective analgesic daily dose. Inadequate pain control was defined as severe/extreme OA pain in the past 30 days from a modified Western Ontario and McMaster Universities Osteoarthritis Index.
Results: Just over half (51.4%) reported taking at least one non-opioid analgesic and approximately 10% was taking an opioid, most (88.5%) of whom also took a non-opioid. One in five participants (19.3%) had inadequate pain control, 39% of whom were using <1 standardized daily dose of either a non-opioid or opioid analgesic. In adjusted analyses, severe/extreme OA pain was significantly associated with both non-opioid (adjusted odds ratio [AOR] = 2.44; 95% confidence interval [95% CI] = 1.49-3.99) and opioid (AOR = 2.64; 95% CI = 1.26-5.53) use.
Conclusions: Although older adults with severe/extreme knee and/or hip OA pain are more likely to take analgesics than those with less severe pain, a sizable proportion takes less than therapeutic doses and thus may be undertreated. Further research is needed to examine barriers to optimal analgesic use.
Wiley Periodicals, Inc.
Conflict of interest statement
None of the authors has any relevant conflict of interest/financial disclosures.
Figures
References
-
- Richmond J, Hunter D, Irrgang J, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am. 2010;92:990–3. - PubMed
-
- Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–62. - PubMed
-
- Fitzcharles MA, Lussier D, Shir Y. Management of chronic arthritis pain in the elderly. Drugs Aging. 2010;27:471–90. - PubMed
-
- Ling SM, Yvette LJ. Osteoarthritis. In: Halter JB, Ouslander JG, Tinetti ME, editors. Hazzard's Geriatric Medicine and Gerontology. 6th. New York: McGraw-Hill; 2009. pp. 289–302.
-
- Hanlon JT, Guay DRP, Ives TJ. Oral analgesics: efficacy, mechanism of action, pharmacokinetics, adverse effects, drug interactions, and practical recommendations for use in older adults. In: Gibson SJ, Weiner DK, editors. Pain in Older Persons, Progress in Pain Research and Management. Seattle: IASP Press; 2005. pp. 205–22.
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- N01-AG-6-2101/AG/NIA NIH HHS/United States
- R01 NR010135/NR/NINR NIH HHS/United States
- N01-AG-6-2103/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- N01-AG-6-2106/AG/NIA NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- R56 AG027017/AG/NIA NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
